Timo Frensing

Director at Bayer

Speaker

Timo Frensing studied biology at the university of Bielefeld, Germany and did there a PhD in the field of molecular cell biology. Afterwards, he became a group leader at the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg, Germany where he led the Molecular Biology Group within the department Bioprocess Engineering focusing on cell culture-based vaccine production. In 2016 he joined the company Roche Diagnostics in Penzberg, Germany where he performed upstream process development within the Pharma Research and Early Development function. Since September 2021 he has been working at Bayer in Wuppertal, Germany in the upstream process development focusing mainly on the expression of biologics in CHO cells.